all report title image
  • Published In : Mar 2024
  • Code : CMI422
  • Pages : 120
  • Formats :
      Excel/PDF
  • Industry : Clinical Diagnostic

Global HIV diagnostics test market is estimated to be valued at USD 4.44 BN in 2024 and is expected to exhibit a CAGR of 9.2% during the forecast period (2024-2031). The HIV diagnostics test market has seen significant growth over the past few decades and is expected to grow substantially going forward. This is mainly due to the rise in number of people impacted by HIV/AIDS globally. Early detection of HIV infection plays a vital role in controlling the spread of the disease as well as improves the quality of life of infected individuals with timely treatment initiation. Advancements in diagnostic technologies have enabled development of rapid, simple, and point-of-care HIV testing kits which have improved accessibility and uptake of HIV testing services across all settings.

Market Dynamics:

The global HIV diagnostics test market growth is driven by the rising prevalence of HIV/AIDS infections worldwide. According to WHO, around 38 million people were living with HIV in 2020. Favorable government initiatives and regulations regarding HIV/AIDS diagnosis & management also boost the market growth. However, lack of awareness about HIV/AIDS in developing nations and social stigma associated with the disease hamper widespread adoption of diagnostic tests. On the other hand, ongoing R&D towards development of novel diagnostic platforms with enhanced sensitivity and shorter turn-around-time presents multiple growth opportunities in the market.

Key Features of the Study:

  • This report provides in-depth analysis of the global HIV diagnostics test market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global HIV diagnostics test market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Abbott, Bio-Rad Laboratories Inc., Hologic Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd., Beckman Coulter Inc., OraSure Technologies Inc., Becton Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems Inc., Zyomyx Incorporation, Bristol –Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global HIV diagnostics test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV diagnostics test market.

Market Segmentation

  • Product:
    • Assay Kit
    • Consumables
  • Test Type:
    • Antibody Test
    • Antigen/antibody tests
    • Nucleic Acid Test
  • End User:
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Homecare Settings
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott
    • Bio-Rad Laboratories Inc.
    • Hologic Inc.
    • Siemens Healthineers
    • Hoffmann-La Roche Ltd.
    • Beckman Coulter Inc.
    • OraSure Technologies Inc.
    • Becton Dickinson and Company
    • Merck KGaA
    • Chembio Diagnostic Systems Inc.
    • Zyomyx Incorporation
    • Bristol –Myers Squibb
    • Janssen Pharmaceutica NV
    • QIAGEN N.V.
    • ViiV Healthcare Ltd.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product
      • Market Snapshot, By Test Type
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Technology Overview
    • Regulatory Scenario
    • PEST Analysis
  4. HIV Diagnostics Test Market- Impact of Coronavirus (Covid-19) Pandemic
    • Overall Impact
    • Impact on Supply and Demand
    • COVID-19 Impact on the market
  5. HIV Diagnostics Test Market, By Product, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Assay Kit
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Consumables
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  6. HIV Diagnostics Test Market, By Test Type, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Antibody Test
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Antigen/antibody tests
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Nucleic Acid Test
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  7.  HIV Diagnostics Test Market, By End User, 2019 – 2031, (USD BN)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospitals & Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Diagnostic Laboratories
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Homecare Settings
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
  8. HIV Diagnostics Test Market, By Region, 2019 – 2031, (USD BN)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Regions, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 – 2031, (USD BN
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 – 2031, (USD BN
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 – 2031, (USD BN
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 – 2031, (USD BN
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 – 2031, (USD BN
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
      • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 – 2031, (USD BN
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Abbot
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hologic Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Siemens Healthineers
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Beckman Coulter Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • OraSure Technologies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Becton Dickinson and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biosynex SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zyomyx Incorporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bristol –Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Janssen Pharmaceutica NV
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • QIAGEN N.V.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ViiV Healthcare Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  10. Analyst View
    1. Wheel of Fortune
    2. Analyst View
    3. Coherent Opportunity Map
  11. References and Research Methodology
    1. References
    2. Research Methodology
    3. About us and Sales Contact

*Browse 19 market data tables and 28 figures on “Global HIV Diagnostics Test Market” - forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.